The Foxo family: Partners in crime or silent heroes

Endocrinology

Volumn 153, Issue 2, 2012, Pages 549-551

  Estall, Jennifer L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO;

DIABETES MELLITUS; ENERGY METABOLISM; GENE EXPRESSION; GLUCOSE METABOLISM; INSULIN RESISTANCE; LIVER FUNCTION; METABOLIC REGULATION; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; TRANSCRIPTION REGULATION;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; HYPERLIPIDEMIAS; HYPOGLYCEMIA; LIVER;

EID: 84856106525     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-2080     Document Type: Short Survey

References (16)

1. Accili D, Arden KC 2004 FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421-426 (Pubitemid 38610228)
2. Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA 2003 Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301:215-218 (Pubitemid 36858475)
3. Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, Miao L, Tothova Z, Horner JW, Carrasco DR, Jiang S, Gilliland DG, Chin L, Wong WH, Castrillon DH, DePinho RA 2007 FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128:309-323 (Pubitemid 46123514)
4. Zhang K, Li L, Qi Y, Zhu X, Gan B, DePinho RA, Averitt T, Guo S 2012 Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. Endocrinology 153:631-646
5. Le Lay J, Kaestner KH 2010 The Fox genes in the liver: from organogenesis to functional integration. Physiol Rev 90:1-22
6. Haeusler RA, Kaestner KH, Accili D 2010 FoxOs function synergistically to promote glucose production. J Biol Chem 285:35245-35248
7. Tao R, Wei D, Gao H, Liu Y, DePinho RA, Dong XC 2011 Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene. J Biol Chem 286:14681-14690
8. Greer EL, Brunet A 2005 FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24:7410-7425 (Pubitemid 41637981)
9. Matsumoto M, Han S, Kitamura T, Accili D 2006 Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116:2464-2472 (Pubitemid 44330145)
10. Ni YG, Wang N, Cao DJ, Sachan N, Morris DJ, Gerard RD, Kuro-O M, Rothermel BA, Hill JA 2007 FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci USA 104:20517-20522
11. Haeusler RA, Han S, Accili D 2010 Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia. J Biol Chem 285:26861-26868
12. Dong XC, Copps KD, Guo S, Li Y, Kollipara R, DePinho RA, White MF 2008 Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 8:65-76 (Pubitemid 351863393)
13. Kharitonenkov A, Shanafelt AB 2009 FGF21: a novel prospect for the treatment of metabolic diseases. Curr Opin Investig Drugs 10:359-364
14. Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, Meseck M, Dong HH 2008 FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest 118:2347-2364
15. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D 2007 Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 6:208-216 (Pubitemid 47336849)
16. Kubota N, Kubota T, Itoh S, Kumagai H, Kozono H, Takamoto I, Mineyama T, Ogata H, Tokuyama K, Ohsugi M, Sasako T, Moroi M, Sugi K, Kakuta S, Iwakura Y, Noda T, Ohnishi S, Nagai R, Tobe K, Terauchi Y, Ueki K, Kadowaki T 2008 Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab 8:49-64 (Pubitemid 351859226)